Cryptococcal Antigen Screening

Cryptococcal Antigen Screening is a clinical laboratory method that detects the presence of cryptococcal polysaccharide antigen in blood or cerebrospinal fluid to identify early asymptomatic infection in immunocompromised individuals, particularly those with HIV, thereby enabling preemptive treatment to prevent cryptococcal meningitis.

327

Publications

17.2K

Citations

1.7K

Authors

647

Institutions

Publications per year

2017–2026

88

Variants

Crag Screening

Authors

1.7K

  1. DR
    David R. Boulware

    University of Minnesota, United States

    27 publications · 1.5K citations

    20

    h-index

  2. DB
    David B. Meya

    Makerere University, Uganda

    23 publications · 1.3K citations

    18

    h-index

  3. RR
    Radha Rajasingham

    University of Minnesota, United States

    18 publications · 842 citations

    16

    h-index

  4. TS
    Thomas S. Harrison

    St George's, University of London, United Kingdom

    18 publications · 1.4K citations

    16

    h-index

  5. JN
    Joseph N Jarvis

    London School of Hygiene & Tropical Medicine, United Kingdom

    18 publications · 1.3K citations

    15

    h-index

1–5 of 1.7K

Venues

  1. Journal of Clinical Microbiology

    JCM · 33 publications · 1.8K citations

    26

    h-index

  2. Clinical Infectious Diseases

    CID · 29 publications · 3.2K citations

    21

    h-index

  3. PLoS ONE

    21 publications · 892 citations

    17

    h-index

  4. PubMed

    Repository · 26 publications · 773 citations

    16

    h-index

  5. Medical Mycology

    17 publications · 595 citations

    15

    h-index

1–5